Genzyme Corporate Homepage

We change the whole destiny
for generations of a family.”

—

Dr. Wayne Trebbin, Founder, World Organization of Renal Therapies. Yaounde, Cameroon

Everybody has a role to play,
and in that role, you are helping someone to live.”

—

Wally Amorin, Director of Label and Packaging. Massachusetts, USA

We have found not only a good company that produces wonderful medicine for our kids, but we have found wonderful people as well.”

—

Ramon Eulacio, father of Veronica, Genzyme patient. Indiana, USA

Running on behalf of my patient partner Rebecca, and making that personal connection with her, has been truly life-changing.”

—

Phil Maderia, Genzyme Running Team, Boston Marathon. Massachusetts, USA

Company Products Research Patients Responsibility Careers

News April 24, 2013 Once-daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study More

More News April 18, 2013 ▪ Genzyme Convenes 13th European Fabry Disease Roundtable April 08, 2013 ▪ Genzyme’s Once-daily, Oral AUBAGIO® (teriflunomide) Approved in A...
Products Celebrating 10 Years
This month marks the ten-year anniversary of U.S. approval for two of our rare disease therapies, Fabrazyme® (agalsidase beta) and Aldurazyme® (laronidase).

Both of these therapies were the first approved treatments for their respective disease areas. Genzyme is committed to continuing to innovate on behalf of patients and address previously unmet medical needs. Learn more
Patients What’s Your Motto? World MS Day is May 29. Organized by the MS International Federation (MSIF), this year’s theme is “What’s Your Motto?” More about World MS Day

Genzyme’s motto is “Challenge Accepted.” Though MS is a complex disease, we are committed to rising to the challenge and innovating on behalf of those affected by MS. More about our MS business unit.

Positive Outlook in a Challenging Environment